A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2004
12/01/2004	EP1480648A1 Anti-viral compounds
12/01/2004	EP1480646A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
12/01/2004	EP1480644A2 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480595A2 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
12/01/2004	EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/01/2004	EP1480517A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
12/01/2004	EP1263761B1 Compounds for pdt
12/01/2004	EP1261355B1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/01/2004	EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
12/01/2004	EP1082422B1 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation
12/01/2004	EP1073745B1 Immunization against and treatment for infection by h. pylori
12/01/2004	EP1012180B1 Hepatitis c inhibitor peptide analogues
12/01/2004	EP0994697B1 Rapamycin formulations for oral administration
12/01/2004	CN1551913A Infectious bovine viral diarrhea virus clone and production method and use
12/01/2004	CN1551887A Novel depsipeptides and process for preparing same
12/01/2004	CN1551881A Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
12/01/2004	CN1551880A Crystalline forms of valacyclovir hydrochloride
12/01/2004	CN1551877A Piperidine derivatives useful as CCR5 antagonists
12/01/2004	CN1551872A Biologically active methylene blue derivatives
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551782A Chimeric flavivirus vectors
12/01/2004	CN1551781A One dose vaccination with mycoplasma hyopneumoniae
12/01/2004	CN1551777A Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551761A Inhibitors of acyl glucosaminyl inositol amidase and methods of use
12/01/2004	CN1551728A Production of transduced hematopoietic progenitor cells
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550236A Protein stability in aqueous solution
12/01/2004	CN1177927C Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgruop B
12/01/2004	CN1177865C Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
12/01/2004	CN1177863C Attenuated microorganisms for treatment of infection
12/01/2004	CN1177861C Macrocylic peptides active against the hepatitis V virus
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177858C Beta, beta-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-N-ethenyl-9a-homoerythromycin A
12/01/2004	CN1177852C Phosphonic diester derivatives
12/01/2004	CN1177834C Dihydroxyhexanoic acid derivatives
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177594C Formulation for use in prevention of pathogen induced diseases including HIV and HSV
12/01/2004	CN1177592C Use of manyinflorescenced sweetvetch extract total saponin in preparing myocarditis treating medicine
12/01/2004	CN1177591C Medicaments that contain xenogenic oligo-or/and polyribonucleotides
11/2004
11/30/2004	US6825350 Administering dosage of immunology response moderator
11/30/2004	US6825327 Process for preparing 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
11/30/2004	US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004	US6825225 Bicyclic isoxazolinones as antibacterial agents
11/30/2004	US6825218 Encapsulated crystal form for oral suspensions without bad taste
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825210 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, n-oxides; 3,7-dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825187 Carbapenem derivatives substituted at the 2-position with a substituted imidazo(5,1-b)thiazole group; use against antibiotic resistant staphylococcus aureus and pseudomonas aeruginosa, enterococci and influenza virus
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825172 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
11/30/2004	US6825170 Erythromycin type macrolide with a fused oxazolone ring
11/30/2004	US6825027 Method of production of purified hepatitis a virus particles and vaccine preparation
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824784 Cold-adapted equine influenza viruses
11/30/2004	US6824783 Delaying the onset of aids in an hiv- 1 infected individual, comprising administering a peptide which inhibits membrane fusion-associated events, i.e. syncytia formation between hiv-1 infected cells and cells uninfected
11/30/2004	US6824769 Compositions comprise alpha-interferon or a derivative thereof and an inosine monophosphate dehydrogenase inhibitor; hepatitis virus
11/30/2004	CA2468118A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering rna precursors enabling the formation and function of small interfering rna in vivo and in vitro
11/30/2004	CA2322540C Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2265461C Compositions and methods for topical application of therapeutic agents
11/30/2004	CA2103062C Oligo-2'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
11/30/2004	CA2089309C Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
11/30/2004	CA2075189C Method and compositions for the synthesis of bch-189 and related compounds
11/25/2004	WO2004101781A1 Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors
11/25/2004	WO2004101776A2 Novel uses of ppar modulators and professional apcs manipulated by the same
11/25/2004	WO2004101622A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats 06 of pseudomonas aeruginosa
11/25/2004	WO2004101605A1 Hepatitis c inhibiting compounds
11/25/2004	WO2004101591A1 NEW 3-DECLADINOSYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A
11/25/2004	WO2004101584A1 Macrolides substituted at the 3-position having antimicrobial activity
11/25/2004	WO2004101571A1 Cephem compounds
11/25/2004	WO2004101552A1 Oxazolidinone derivatives as antibacterial agents
11/25/2004	WO2004101543A1 Coumarins compounds, the preparation and the use thereof
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101502A1 Polyene polyketides, processes for their production and their use as pharmaceuticals
11/25/2004	WO2004100995A1 Targeted delivery of anti-viral compounds through hemoglobin bioconjugation
11/25/2004	WO2004100982A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	WO2004100980A1 Interferon for treating or preventing a coronaviral infection
11/25/2004	WO2004100974A1 USE OF Hab 18G/CD 147 MOLECULE AS TARGET OF ANTIVIRAL ANTAGONIST AND THUS OBTAINED ANTIVIRAL ANTAGONIST
11/25/2004	WO2004100973A2 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases.
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100966A1 Preparation for preventing contact of pathogenic matter with living organism
11/25/2004	WO2004100877A2 Vaccine accelerator factor (vaf) for poultry
11/25/2004	WO2004100861A2 Pharmaceutical composition comprising lectin
11/25/2004	WO2004091637A3 System capable of treating and defining various diseases using stem cells
11/25/2004	WO2004085479A3 Treatment of viral infections
11/25/2004	WO2004084856A3 Novel galenical system for active transport, method for preparation and use
11/25/2004	WO2004071416B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/25/2004	WO2004069255A3 Use of quinazoline derivatives or other compounds for inhibiting dihydrofolate reduxtase; screening assay for the identification of novel therapeutics and their cellular targets
11/25/2004	WO2004067567A3 Anti-dengue virus antibodies, compositions, methods and uses
11/25/2004	WO2004054498A3 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
11/25/2004	WO2004004683A8 Solid dispersions comprising two different polymer matrixes

1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 1798